Shanghai Neo-leading Pharmaceutical Co., Ltd. Is a subsidiary of BociMed engaged in synthesis technology, which is committed to providing efficient and high-quality services and products to global new drug companies with the goal of rapid compliance delivery. Neo-leading focusing on the development and manufacturing of molecular masonry processes for small molecules, peptides, and small nucleic acids. We also provide FTE services, analytical and testing services, CMC services, and CDMO services for the process development of small molecules and peptide drugs.